x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
|
||
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
|||
For
the quarterly period ended March 31, 2009
|
|||
OR
|
|||
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)
|
||
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
Maryland
|
47-0934168
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(I.R.S.
Employer
Identification
No.)
|
Large
Accelerated Filer o
|
Accelerated
Filer o
|
Non-Accelerated
Filer x
|
Smaller
Reporting Company o
|
PART
I. Financial Information
|
2
|
Item 1. Condensed Consolidated Financial
Statements (unaudited)
|
2
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
2
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
3
|
CONDENSED
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
|
4
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
5
|
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
6
|
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of Operations
|
24
|
Item 3. Quantitative and Qualitative
Disclosures about Market Risk
|
39
|
Item 4. Controls and
Procedures
|
44
|
PART
II. OTHER INFORMATION
|
44
|
Item 1A. Risk
Factors
|
44
|
Item 6. Exhibits
|
44
|
SIGNATURE
|
45
|
March
31, 2009
|
December 31,
2008
|
|||||||
ASSETS
|
||||||||
Cash
and cash equivalents
|
$ | 44,990 | $ | 9,387 | ||||
Restricted
cash
|
4,249 | 7,959 | ||||||
Investment
securities - available for sale, at fair value (including pledged
securities of $305,004 and $456,506, respectively)
|
313,630 | 477,416 | ||||||
Receivable
for securities sold
|
18,203 | — | ||||||
Accounts
and accrued interest receivable
|
2,800 | 3,095 | ||||||
Mortgage
loans held in securitization trusts (net)
|
335,980 | 348,337 | ||||||
Derivative
assets
|
9 | 22 | ||||||
Prepaid
and other assets
|
1,502 | 1,230 | ||||||
Assets
related to discontinued operation
|
4,784 | 5,854 | ||||||
Total
Assets
|
$ | 726,147 | $ | 853,300 | ||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Liabilities:
|
||||||||
Financing
arrangements, portfolio investments
|
$ | 276,182 | $ | 402,329 | ||||
Collateralized
debt obligations
|
323,645 | 335,646 | ||||||
Derivative
liabilities
|
4,007 | 4,194 | ||||||
Payable
for securities purchased
|
8,998 | — | ||||||
Accounts
payable and accrued expenses
|
4,001 | 3,997 | ||||||
Subordinated
debentures (net)
|
44,687 | 44,618 | ||||||
Convertible
preferred debentures (net)
|
19,739 | 19,702 | ||||||
Liabilities
related to discontinued operation
|
3,371 | 3,566 | ||||||
Total
liabilities
|
684,630 | 814,052 | ||||||
Commitments
and Contingencies
|
||||||||
Stockholders’
Equity:
|
||||||||
Common
stock, $0.01 par value, 400,000,000 authorized, 9,320,094 and 9,320,094,
shares issued and outstanding, respectively
|
93 | 93 | ||||||
Additional
paid-in capital
|
149,112 | 150,790 | ||||||
Accumulated
other comprehensive loss
|
(6,628 | ) | (8,521 | ) | ||||
Accumulated
deficit
|
(101,060 | ) | (103,114 | ) | ||||
Total
stockholders’ equity
|
41,517 | 39,248 | ||||||
Total
Liabilities and Stockholders’ Equity
|
$ | 726,147 | $ | 853,300 |
For
the Three Months Ended March 31,
|
||||||||
2009
|
2008
|
|||||||
REVENUE:
|
||||||||
Interest
income-investment securities and loans held in securitization
trusts
|
$ | 8,585 | $ | 13,253 | ||||
Interest
expense-investment securities and loans held in securitization
trusts
|
3,130 | 10,514 | ||||||
Net
interest income from investment securities and loans held in
securitization trusts
|
5,455 | 2,739 | ||||||
Interest
expense – subordinated debentures
|
(824 | ) | (959 | ) | ||||
Interest
expense – convertible preferred debentures
|
(537 | ) | (506 | ) | ||||
Net
interest income
|
4,094 | 1,274 | ||||||
OTHER
EXPENSE:
|
||||||||
Provision
for loan losses
|
(629 | ) | (1,433 | ) | ||||
Impairment
loss on investment securities
|
(119 | ) | — | |||||
Realized
gain (loss) on securities and related hedges
|
123 | (19,848 | ) | |||||
Total
other expense
|
(625 | ) | (21,281 | ) | ||||
EXPENSE:
|
||||||||
Salaries
and benefits
|
541 | 313 | ||||||
Professional
fees
|
341 | 352 | ||||||
Management
fees
|
182 | 109 | ||||||
Insurance
|
92 | 180 | ||||||
Other
|
414 | 477 | ||||||
Total
expenses
|
1,570 | 1,431 | ||||||
INCOME
(LOSS) FROM CONTINUING OPERATIONS
|
1,899 | (21,438 | ) | |||||
Income
from discontinued operation - net of tax
|
155 | 180 | ||||||
NET
INCOME (LOSS)
|
$ | 2,054 | $ | (21,258 | ) | |||
Basic
income (loss) per common share
|
$ | 0.22 | $ | (4.19 | ) | |||
Diluted
income (loss) per common share
|
$ | 0.22 | $ | (4.19 | ) | |||
Dividends
declared per share common share
|
$ | 0.18 | $ | — | ||||
Weighted
average shares outstanding-basic
|
9,320 | 5,070 | ||||||
Weighted
average shares outstanding-diluted
|
11,820 | 5,070 |
Common
Stock
|
Additional
Paid-In
Capital
|
Accumulated
Deficit
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Comprehensive
Income
|
Total
|
|||||||||||||||||||
Balance,
January 1, 2009
|
$ | 93 | $ | 150,790 | $ | (103,114 | ) | $ | (8,521 | ) | $ | 39,248 | ||||||||||||
Net
income
|
— | — | 2,054 | — | $ | 2,054 | 2,054 | |||||||||||||||||
Dividends
declared
|
— | (1,678 | ) | — | — | — | (1,678 | ) | ||||||||||||||||
Increase
in net unrealized gain on investment available for sale
securities
|
— | — | — | 1,478 | 1,478 | 1,478 | ||||||||||||||||||
Increase
in derivative instruments utilized for cash flow
hedge
|
— | — | — | 415 | 415 | 415 | ||||||||||||||||||
Comprehensive
income
|
— | — | — | — | $ | 3,947 | ||||||||||||||||||
Balance,
March 31, 2009
|
$ | 93 | $ | 149,112 | $ | (101,060 | ) | $ | (6,628 | ) | $ | 41,517 |
For the Three Months
Ended March
31,
|
||||||||
2009
|
2008
|
|||||||
Cash
Flows from Operating Activities:
|
||||||||
Net
income (loss)
|
$ | 2,054 | $ | (21,258 | ) | |||
Adjustments
to reconcile net loss to net cash provided by (used in)
operating activities:
|
||||||||
Depreciation
and amortization
|
353 | 332 | ||||||
(Accretion)
Amortization of (discount) premium on investment securities and mortgage
loans held in securitization trusts
|
(98 | ) | 224 | |||||
(Gain)loss
on securities and related hedges
|
(123 | ) | 19,848 | |||||
Impairment
loss on investment securities
|
119 | — | ||||||
Provision
for loan losses
|
629 | 1,109 | ||||||
Lower
of cost or market adjustments
|
103 | 86 | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Accounts
and accrued interest receivable
|
303 | 724 | ||||||
Prepaid
and other assets
|
(281 | ) | 540 | |||||
Due
to loan purchasers
|
(19 | ) | 500 | |||||
Accounts
payable and accrued expenses
|
(1,687 | ) | (3,039 | ) | ||||
Payments
received on loans held for sale
|
961 | 1,782 | ||||||
Net
cash provided by operating activities:
|
2,314 | 848 | ||||||
Cash
Flows from Investing Activities:
|
||||||||
Decrease
in restricted cash
|
3,710 | 6,146 | ||||||
Purchases
of investment securities
|
(7,728 | ) | (801,746 | ) | ||||
Proceeds
from sale of investment securities
|
144,502 | 587,704 | ||||||
Principal
repayments received on mortgage loans held in securitization
trusts
|
11,492 | 30,754 | ||||||
Principal
paydown on investment securities - available for sale
|
19,510 | 25,602 | ||||||
Net
cash provided (used in) by investing activities
|
171,486 | (151,540 | ) | |||||
Cash
Flows from Financing Activities:
|
||||||||
Proceeds
from common stock issued (net)
|
— | 56,628 | ||||||
Proceeds
from convertible preferred debentures
(net)
|
— | 19,590 | ||||||
Payments
made for termination of swaps
|
— | (8,333 | ) | |||||
(Decrease)
increase in financing arrangements
|
(126,147 | ) | 115,934 | |||||
Collateralized
debt obligation paydowns
|
(12,050 | ) | (30,623 | ) | ||||
Net
cash (used in) provided by financing activities
|
(138,197 | ) | 153,196 | |||||
Net
Increase in Cash and Cash Equivalents
|
35,603 | 2,504 | ||||||
Cash
and Cash Equivalents - Beginning of Period
|
9,387 | 5,508 | ||||||
Cash
and Cash Equivalents - End of Period
|
$ | 44,990 | $ | 8,012 | ||||
Supplemental
Disclosure
|
||||||||
Cash
paid for interest
|
$ | 4,033 | $ | 11,689 | ||||
Non Cash Investing Activities | ||||||||
Purchase of investment securities | $ | 8,998 | $ | — | ||||
Proceeds from sale of investment securities | $ | 18,203 | $ | — | ||||
Non
Cash Financing Activities
|
||||||||
Dividends
declared to be paid in subsequent period
|
$ | 1,678 | $ | — |
1.
|
Organization
and Summary of Significant Accounting
Policies
|
2.
|
Investment
Securities - Available for Sale
|
Amortized
Cost
|
Unrealized
Gains
|
Unrealized
Losses
|
Carrying
Value
|
|||||||||||||
Agency
Hybrid ARM Securities
|
$ | 248,467 | 3,007 | — | $ | 251,474 | ||||||||||
Agency
REMIC CMO Floaters
|
33,135 | 142 | — | 33,277 | ||||||||||||
Private
Label CMO Floaters
|
23,836 | — | (4,499 | ) | 19,337 | |||||||||||
Collateralized
Loan Obligations
|
8,998 | — | — | 8,998 | ||||||||||||
NYMT
Retained Securities
|
677 | — | (133 | ) | 544 | |||||||||||
Total
|
$ | 315,113 | 3,149 | (4,632 | ) | $ | 313,630 |
Amortized
Cost
|
Unrealized
Gains
|
Unrealized
Losses
|
Carrying
Value
|
|||||||||||||
Agency
Hybrid Arm Securities
|
$ | 256,978 | $ | 1,316 | $ | (98 | ) | $ | 258,196 | |||||||
Agency
REMIC CMO Floaters
|
197,675 | — | — | 197,675 | ||||||||||||
Private
Label Floaters
|
25,047 | — | (4,101 | ) | 20,946 | |||||||||||
NYMT
Retained Securities
|
677 | — | (78 | ) | 599 | |||||||||||
Total
|
$ | 480,377 | $ | 1,316 | $ | (4,277 | ) | $ | 477,416 |
Less than 6 Months
|
More than 6
Months
to 24 Months
|
More than 24
Months
to 60 Months
|
Total
|
|||||||||||||||||||||||||||||
Carrying
Value
|
Weighted
Average
Yield
|
Carrying
Value
|
Weighted
Average
Yield
|
Carrying
Value
|
Weighted
Average
Yield
|
Carrying
Value
|
Weighted
Average
Yield
|
|||||||||||||||||||||||||
Agency
Hybrid ARM Securities
|
$ | — | — | $ | 62,844 | 3.59 | % | $ | 188,630 | 4.02 | % | $ | 251,474 | 3.92 | % | |||||||||||||||||
Agency
REMIC CMO Floaters
|
33,277 | 6.39 | % | — | — | — | — | 33,277 | 6.39 | % | ||||||||||||||||||||||
Private
Label CMO Floaters
|
19,337 | 14.23 | % | — | — | — | — | 19,337 | 14.23 | % | ||||||||||||||||||||||
Collateralized
Loan Obligations
|
8,998 | 25.28 | % | — | — | — | — | 8,998 | 25.28 | % | ||||||||||||||||||||||
NYMT
Retained Securities (1)
|
475 | 15.00 | % | 69 | 19.10 | % | — | — | 544 | 15.52 | % | |||||||||||||||||||||
Total/Weighted
average
|
$ | 62,087 | 11.64 | % | $ | 62,913 | 3.61 | % | $ | 188,630 | 4.02 | % | $ | 313,630 | 5.45 | % |
|
(1)
|
The
NYMT retained securities includes $0.1 million of residual interests
related to the NYMT 2006-1
transaction.
|
Less than 6 Months
|
More than 6
Months
to 24 Months
|
More than 24
Months
to 60 Months
|
Total
|
|||||||||||||||||||||||||||||
Carrying
Value
|
Weighted
Average
Yield
|
Carrying
Value
|
Weighted
Average
Yield
|
Carrying
Value
|
Weighted
Average
Yield
|
Carrying
Value
|
Weighted
Average
Yield
|
|||||||||||||||||||||||||
Agency
Hybrid ARM Securities
|
$ | — | — | $ | 66,910 | 3.69 | % | $ | 191,286 | 4.02 | % | $ | 258,196 | 3.93 | % | |||||||||||||||||
Agency
REMIC CMO Floaters
|
197,675 | 8.54 | % | — | — | — | — | 197,675 | 8.54 | % | ||||||||||||||||||||||
Private
Label CMO Floaters
|
20,946 | 14.25 | % | — | — | — | — | 20,946 | 14.25 | % | ||||||||||||||||||||||
NYMT
Retained Securities (1)
|
530 | 8.56 | % | — | — | 69 | 16.99 | % | 599 | 15.32 | % | |||||||||||||||||||||
Total/Weighted
average
|
$ | 219,151 | 9.21 | % | $ | 66,910 | 3.69 | % | $ | 191,355 | 4.19 | % | $ | 477,416 | 6.51 | % |
|
(1)
|
The
NYMT retained securities includes $0.1 million of residual interests
related to the NYMT 2006-1
transaction.
|
Greater
than 12 months
and
less than 18 months
|
Total
|
|||||||||||||||
Carrying
Value
|
Gross
Unrealized
Losses
|
Carrying
Value
|
Gross
Unrealized
Losses
|
|||||||||||||
Non-Agency
floaters
|
19,337 | 4,499 | 19,337 | 4,499 | ||||||||||||
NYMT
Retained Securities
|
475 | 133 | 475 | 133 | ||||||||||||
Total
|
$ | 19,812 | $ | 4,632 | $ | 19,812 | $ | 4,632 |
Less
than 12 Months
|
Total
|
|||||||||||||||
Carrying
Value
|
Gross
Unrealized
Losses
|
Carrying
Value
|
Gross
Unrealized
Losses
|
|||||||||||||
Agency
Hybrid ARM securities
|
9,406 | 98 | 9,406 | 98 | ||||||||||||
Non-Agency
floaters
|
18,119 | 4,101 | 18,119 | 4,101 | ||||||||||||
NYMT
retained security
|
530 | 78 | 530 | 78 | ||||||||||||
Total
|
$ | 28,055 | $ | 4,277 | $ | 28,055 | $ | 4,277 |
3.
|
Mortgage
Loans Held in Securitization Trusts
(net)
|
March
31,
2009
|
December
31,
2008
|
|||||||
Mortgage
loans principal amount
|
$ | 335,538 | $ | 347,546 | ||||
Deferred
origination costs – net
|
2,122 | 2,197 | ||||||
Reserve
for loan losses
|
(1,680 | ) | (1,406 | ) | ||||
Total
|
$ | 335,980 | $ | 348,337 |
March
31,
|
||||||||
2009
|
2008
|
|||||||
Balance at
beginning of period
|
$ | 1,406 | $ | 1,647 | ||||
Provisions
for loan losses
|
629 | 1,433 | ||||||
Charge-offs
|
(355 | ) | — | |||||
Balance
of the end of period
|
$ | 1,680 | $ | 3,080 |
March
31, 2009
|
||||||||||||
Days
Late
|
Number
of
Delinquent
Loans
|
Total
Dollar
Amount
|
%
of Loan
Portfolio
|
|||||||||
30-60
|
7
|
$ | 4,686 | 1.40% | ||||||||
61-90
|
4
|
1,262 | 0.38% | |||||||||
90+
|
12
|
4,672 | 1.39% | |||||||||
Real
estate owned through foreclosure
|
3
|
816 | 0.24% |
December
31, 2008
|
||||||||||||
Days
Late
|
Number
of
Delinquent
Loans
|
Total
Dollar
Amount
|
%
of Loan
Portfolio
|
|||||||||
30-60
|
3
|
$ | 1,363 | 0.39% | ||||||||
61-90
|
1
|
263 | 0.08% | |||||||||
90+
|
13
|
5,734 | 1.65% | |||||||||
Real
estate owned through foreclosure
|
4
|
1,927 | 0.55% |
4.
|
Derivative
Instruments and Hedging Activities
|
Derivative
Designated as Hedging
Instruments
Under SFAS 133
|
Balance
Sheet Location
|
March
31, 2009
|
December
31, 2008
|
|||||||
Interest
Rate Caps
|
Derivative
Assets
|
$ | 9 | $ | 22 | |||||
Interest
Rate Swaps
|
Derivative
Liabilities
|
$ | 4,007 | $ | 4,194 |
Derivative
Designated as Hedging Instruments Under SFAS 133
|
March
31, 2009
|
March
31, 2008
|
||||||
Accumulated
other comprehensive loss for derivative instruments:
|
||||||||
Balance
at beginning of the period
|
$ | (5,560 | ) | $ | (1,951 | ) | ||
Unrealized
gain (losses) on interest rate caps
|
229 | (54 | ) | |||||
Unrealized
gain (losses) on interest rate swaps
|
187 | (1,169 | ) | |||||
Reclassification
adjustment for net losses included in net income for
hedges
|
— | — | ||||||
Balance
at the end of the period
|
$ | (5,144 | ) | $ | (3,174 | ) |
Derivative
Designated as Hedging Instruments Under SFAS 133
|
March
31, 2009
|
March
31, 2008
|
||||||
Interest
Rate Caps:
|
||||||||
Interest
expense-investment securities and loans held in securitization
trusts
|
$ | 160 | $ | 189 | ||||
Interest
expense-subordinated debentures
|
81 | (1 | ) | |||||
Interest
Rate Swaps:
|
||||||||
Interest
expense-investment securities and loans held in securitization
trusts
|
853 | (16 | ) |
March
31, 2009
|
December
31, 2008
|
|||||||||||||||||
Maturity
(1)
|
Notional
Amount
|
Weighted
Average Fixed Pay Interest Rate
|
Notional
Amount
|
Weighted
Average Fixed Pay Interest Rate
|
||||||||||||||
Within
30 Days
|
$ | 2,700 | 2.99 | % | $ | 2,960 | 3.00 | % | ||||||||||
Over
30 days to 3 months
|
5,070 | 2.99 | 5,220 | 3.00 | ||||||||||||||
Over
3 months to 6 months
|
7,410 | 2.99 | 7,770 | 2.99 | ||||||||||||||
Over
6 months to 12 months
|
12,210 | 2.99 | 13,850 | 2.99 | ||||||||||||||
Over
12 months to 24 months
|
69,060 | 3.01 | 48,640 | 2.99 | ||||||||||||||
Over
24 months to 36 months
|
13,370 | 3.02 | 34,070 | 3.03 | ||||||||||||||
Over
36 months to 48 months
|
19,270 | 3.07 | 7,560 | 3.01 | ||||||||||||||
Over
48 monhts
|
— | — | 17,200 | 3.08 | ||||||||||||||
Total
|
$ | 129,090 | 3.00 | % | $ | 137,270 | 3.00 | % |
(1)
|
The
Company enters into scheduled amortizing interest rate swap transactions
whereby the Company pays a fixed rate of interest and receives one month
LIBOR.
|
5.
|
Financing
Arrangements, Portfolio Investments
|
6.
|
Collateralized
Debt Obligations
|
7.
|
Discontinued
Operation
|
March
31,
2009
|
December
31,
2008
|
|||||||
Accounts
and accrued interest receivable
|
$ | 18 | $ | 26 | ||||
Mortgage
loans held for sale(net)
|
4,313 | 5,377 | ||||||
Prepaid
and other assets
|
453 | 451 | ||||||
Total assets
|
$ | 4,784 | $ | 5,854 |
March
31,
2009
|
December
31,
2008
|
|||||||
Due
to loan purchasers
|
$ | 527 | $ | 708 | ||||
Accounts
payable and accrued expenses
|
2,844 | 2,858 | ||||||
Total liabilities
|
$ | 3,371 | $ | 3,566 |
For
the Three Months Ended
|
||||||||
March 31, | ||||||||
2009
|
2008
|
|||||||
Revenues
|
$ | 290 | $ | 171 | ||||
Expenses
|
135 | (9 | ) | |||||
Income
from discontinued operation – net of tax
|
$ | 155 | $ | 180 |
8.
|
Commitments
and Contingencies
|
9.
|
Concentrations
of Credit Risk
|
March
31, 2009
|
December
31, 2008
|
|||||||
New
York
|
31.0 % | 30.7% | ||||||
Massachusetts
|
17.5 % | 17.2 % | ||||||
Florida
|
7.8 % | 7.8 % | ||||||
California
|
7.5 % | 7.2 % | ||||||
New
Jersey
|
6.1 % | 6.0 % |
10.
|
Fair
Value of Financial Instruments
|
Asset
Measured at Fair Value on a Recurring Basis at March 31,
2009
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Assets
carried at fair value:
|
||||||||||||||||
Investment
securities available for sale
|
$
|
—
|
$
|
304,632
|
$
|
8,998
|
$
|
313,630
|
||||||||
Derivative
assets (interest rate caps)
|
—
|
9
|
—
|
9
|
||||||||||||
Total
|
$
|
—
|
$
|
304,641
|
$
|
8,998
|
$
|
313,639
|
Liabilities
carried at fair value:
|
||||||||||||||||
Derivative
liabilities (interest rate swaps)
|
$
|
—
|
$
|
4,007
|
$
|
—
|
$
|
4,007
|
||||||||
Total
|
$
|
—
|
$
|
4,007
|
$
|
—
|
$
|
4,007
|
Asset
Measured at Fair Value on a Recurring Basis at December 31,
2008
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Assets
carried at fair value:
|
||||||||||||||||
Investment
securities available for sale
|
$
|
—
|
$
|
477,416
|
$
|
—
|
$
|
477,416
|
||||||||
Derivative
assets (interest rate caps)
|
—
|
22
|
—
|
22
|
||||||||||||
Total
|
$
|
—
|
$
|
477,438
|
$
|
—
|
$
|
477,438
|
Liabilities
carried at fair value:
|
||||||||||||||||
Derivative
liabilities (interest rate swaps)
|
$
|
—
|
$
|
4,194
|
$
|
—
|
$
|
4,194
|
||||||||
Total
|
$
|
—
|
$
|
4,194
|
$
|
—
|
$
|
4,194
|
Assets
Measured at Fair Value on a Non-Recurring Basis
at
March 31, 2009
|
Losses for the Three Months
Ended
|
|||||||||||||||||||
Level
1
|
Level
2
|
Level
3
|
Total
|
March
31, 2009
|
||||||||||||||||
Mortgage
loans held for sale (net)
|
$ | — | $ | — | $ | 4,313 | $ | 4,313 | $ | 103 | ||||||||||
Mortgage
loans held n securitization trusts (net) – impaired loans
|
$ | — | $ | — | $ | 5,874 | $ | 5,874 | $ | 629 |
Assets
Measured at Fair Value on a Non-Recurring Basis
at
December 31, 2008
|
Losses for the Three Months
Ended
|
|||||||||||||||||||
Level
1
|
Level
2
|
Level
3
|
Total
|
March
31, 2008
|
||||||||||||||||
Mortgage
loans held for sale (net)
|
$ | — | $ | — | $ | 5,377 | $ | 5,377 | $ | 398 | ||||||||||
Mortgage
loans held n securitization trusts (net) – impaired loans
|
$ | — | $ | — | $ | 2,958 | $ | 2,958 | $ | 1,433 |
11.
|
Segment
Reporting
|
12.
|
Capital
Stock and Earnings per Share
|
Period
|
Declaration
Date
|
Record
Date
|
Payment
Date
|
Cash
Dividend
Per
Share
|
||||||
First
Quarter 2009
|
March
25, 2009
|
April
6, 2009
|
April
27, 2009
|
$
|
0.18
|
|||||
Fourth
Quarter 2008
|
December
23, 2008
|
January
7, 2009
|
January
26, 2009
|
$
|
0.10
|
|||||
Third
Quarter 2008
|
September
26, 2008
|
October
10, 2008
|
October
27, 2008
|
0.16
|
||||||
Second
Quarter 2008
|
June
30, 2008
|
July
10, 2008
|
July
25, 2008
|
0.16
|
||||||
First
Quarter 2008
|
April
21, 2008
|
April
30, 2008
|
May
15,2008
|
0.12
|
Period
|
Declaration
Date
|
Record
Date
|
Payment
Date
|
Cash
Dividend
Per
Share
|
||||||
First
Quarter 2009
|
March
25, 2009
|
March
31, 2009
|
April
30, 2009
|
$
|
0.50
|
|||||
Fourth
Quarter 2008
|
December
23, 2008
|
December
31, 2008
|
January
30,2009
|
$
|
0.50
|
|||||
Third
Quarter 2008
|
September
26, 2008
|
September
30, 2008
|
October
30, 2008
|
0.50
|
||||||
Second
Quarter 2008
|
June
30, 2008
|
June
30, 2008
|
July
30, 2008
|
0.50
|
||||||
First
Quarter 2008
|
April
21, 2008
|
March
31, 2008
|
April
30,2008
|
0.50
|
For
the Three Months
Ended
March 31
|
||||||||
2009
|
2008
|
|||||||
Numerator:
|
||||||||
Net
income (loss) – Basic
|
$ | 2,054 | $ | (21,258 | ) | |||
Net
income (loss) from continuing operations
|
1,899 | (21,438 | ) | |||||
Net
income from discontinued operation (net of tax)
|
155 | 180 | ||||||
Effect
of dilutive instruments:
|
||||||||
Convertible
preferred debentures (1)
|
537 | 506 | ||||||
Net
income (loss) – Dilutive
|
2,591 | (21,258 | ) | |||||
Net
income (loss) from continuing operations
|
2,436 | (21,438 | ) | |||||
Net
income from discontinued operation (net of tax)
|
$ | 155 | $ | 180 | ||||
Denominator:
|
||||||||
Weighted
average basis shares outstanding
|
9,320 | 5,070 | ||||||
Effect
of dilutive instruments:
|
||||||||
Convertible
preferred debentures (1)
|
2,500 | 2,028 | ||||||
Weighted
average dilutive shares outstanding
|
11,820 | 5,070 | ||||||
Net
Income Per Share:
|
||||||||
Basic
EPS
|
$ | 0.22 | $ | (4.23 | ) | |||
Basic
income (loss) per common share from continuing
operations
|
0.20 | (4.19 | ) | |||||
Basic
income per common share from discontinued operation (net of
tax)
|
0.02 | 0.04 | ||||||
Dilutive
EPS
|
$ | 0.22 | $ | (4.23 | ) | |||
Dilutive
income (loss) per common share from continuing operations
|
0.21 | (4.19 | ) | |||||
Dilutive income
per common share from discontinued operation (net of tax)
|
0.01 | 0.04 |
13.
|
Convertible
Preferred Debentures (net)
|
14.
|
Related
Party Transactions
|
15.
|
Income
Taxes
|
|
·
|
our
business strategy;
|
|
·
|
future
performance, developments, market forecasts or projected
dividends;
|
|
·
|
projected
acquisitions or joint ventures; and
|
|
·
|
projected
capital expenditures.
|
|
·
|
our
portfolio strategy and operating strategy may be changed or modified by
our management without advance notice to you or stockholder approval and
we may suffer losses as a result of such modifications or
changes;
|
|
·
|
our
ability to successfully implement and grow our alternative investment
strategy and to identify suitable alternative
assets;
|
|
·
|
market
changes in the terms and availability of repurchase agreements used to
finance our investment portfolio
activities;
|
|
·
|
reduced
demand for our securities in the mortgage securitization and secondary
markets;
|
|
·
|
interest
rate mismatches between our interest-earning assets and our borrowings
used to fund such purchases;
|
|
·
|
changes
in interest rates and mortgage prepayment
rates;
|
|
·
|
changes
in the financial markets and economy generally, including the continued or
accelerated deterioration of the U.S.
economy;
|
|
·
|
effects
of interest rate caps on our adjustable-rate mortgage-backed
securities;
|
|
·
|
the
degree to which our hedging strategies may or may not protect us from
interest rate volatility;
|
|
·
|
potential
impacts of our leveraging policies on our net income and cash available
for distribution;
|
|
·
|
our
board’s ability to change our operating policies and strategies without
notice to you or stockholder
approval;
|
|
·
|
our
ability to manage, minimize or eliminate liabilities stemming from the
discontinued operation including, among other things, litigation,
repurchase obligations on the sales of mortgage loans and property
leases;
|
|
·
|
actions
taken by the U.S. and foreign governments, central banks and other
governmental and regulatory bodies for the purpose of stabilizing the
financial credit and housing markets, and economy generally, including
loan modification programs;
|
|
·
|
changes
to the nature of the guarantees provided by Fannie Mae and Freddie Mac;
and
|
|
·
|
the
other important factors identified, or incorporated by reference into this
report, including, but not limited to those under the captions
“Management’s Discussion and Analysis of Financial Condition and Results
of Operations” and “Quantitative and Qualitative Disclosures about Market
Risk”, and those described in Part I, Item 1A – “Risk Factors” of our
Annual Report on Form 10-K for the year ended December 31, 2008, and the
various other factors identified in any other documents filed by us with
the SEC.
|
March
31, 2009
|
Sponsor
or Rating
|
Par
Value
|
Carrying
Value
|
%
of
Portfolio
|
Coupon
|
Yield
|
|||||||||||||||
Agency
REMIC CMO floaters
|
FNMA/
FHLMC
|
$ | 34,279 | $ | 33,277 | 11% | 1.43% | 6.39% | |||||||||||||
Agency
Hybrid Arms
|
FNMA
|
243,456 | 251,474 |